BEAM

#1651
Beam Therapeutics Inc. Common Stock
31.00 USD
+2.31%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
30.32
31.00
Intervallo Annuale
15.35
36.44
Variazione giornaliera
+2.31%
Variazione Mensile
+20.62%
Variazione di 6 mesi
+13.35%
Variazione Annuale
+82.68%
Chiusura Precedente
30.30
Apertura
30.32
Bid
Ask
Minimo
30.32
High
31.00
Volume
43
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Beam Therapeutics Inc

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

Notizie